← SynDRA
BUTORPHANOL
SynDRA canonical compound SYN0001803 — structure-anchored drug synonym record
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | OPRM1 |
|---|
| Mechanism of action | Opioid receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Opioid receptor agonist
- Opioid receptor antagonist
- OPRM1 PARTIAL AGONIST
- Mu opioid receptor partial agonist
- OPRK1 PARTIAL AGONIST
- Kappa opioid receptor partial agonist
- OPRD1 AGONIST
Drug classes
- Analgesics
- Analgesics, Opioid
- Antitussive Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Narcotic Antagonists
- Narcotics
- Peripheral Nervous System Agents
- Respiratory System Agents
- Sensory System Agents
- Partial Opioid Agonists
- Competitive Opioid Antagonists
ATC classes
Cross-references
Synonyms
- (-)-Butorphanol
- butorphanol tartrate
- BC-2627
- Butorfanol
- LEVO-BC-2627
- Beforal
- Butorphanolum
- Moradol
- Stadol
- Butorphanol tartrate
- Beforal (TN)
- Butorfanol [INN-Spanish]
- Butorphanolum [INN-Latin]
- L-BC 2627
- Moradol (TN)
- Butorphanol (USAN/INN)
- Butorphanol [USAN:BAN:INN]
- Levo-BC-2627
- (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol
- (-)-N-cyclobutylmethyl-3,14-dihydroxymorphinan
- (-)-butorphanol
- 17-(CYCLOBUTYLMETHYL)MORPHINAN-3,14-DIOL
- butorphanol-(+)-tartrate
- QV897JC36D
- Morphinan-3,14-diol, 17-(cyclobutylmethyl)-
- levo-BC-2627
- CHEBI:3242
- butorfanolo
- BC 2627
- RefChem:56687
- DTXCID502714
- N02AF01
- BC2627
- Butorphanol (free base)
- l-BC 2627
- DEA No. 9720
- EINECS 255-808-8
- UNII-QV897JC36D
Reported adverse events
- NGS
- Abnormal dreams
- Anxiety
- Asthenia
- Epistaxis
- Hypertension
- Hypotension
- Rash
- Allodynia
- Adrenal insufficiency
- Androgen deficiency
- Death
Look up BUTORPHANOL in the interactive SynDRA portal →